\-\ Texto\\:\\ \ \(0\)\
\-\ unknow\\ exam\\.\ \(0\)\
\-\ labs\\ significant\\ for\\:\ \(0\)\
\-\ hemoglobin\\ a1c\\ 6\\.0\\-8\\.0\\ over\\ past\\ 6months\ \(0\)\
\-\ wbc\\ 13\\.0\\-23\\.9\\ over\\ past\\ month\ \(0\)\
\-\ wound\\ cultures\\ negative\\.\ \(0\)\
\-\ for\\ patients\\ with\\ severe\\ joint\\ destruction\\,\\ chronic\\ ulcers\\,\\ and\\ possibly\\ osteomyelitis\\,\\ amputations\\ are\\ typically\\ involved\\ to\\ prevent\\ systemic\\ infection\\.\\ \\ upon\\ presentation\\ iv\\ vancomycin\\ was\\ begun\\ on\\ this\\ patient\\,\\ but\\ was\\ later\\ dicontinued\\ after\\ all\\ wound\\ cultures\\ were\\ negative\\.\\ \\ further\\ follow\\ up\\ is\\ unknown\\.\ \(0\)\
\-\ two\\ images\\ are\\ submitted\\.\\ \\ the\\ one\\ on\\ the\\ right\\ is\\ 6\\ months\\ prior\\ to\\ the\\ one\\ on\\ the\\ left\\.\\ \\ interval\\ worsening\\ of\\ the\\ joint\\ destruction\\ is\\ evident\\.\\ \\ please\\ see\\ the\\ specific\\ captions\\ for\\ the\\ findings\\.\\ \\ however\\,\\ typical\\ radiographic\\ findings\\ include\\:\\ joint\\ destruction\\,\\ disorganization\\,\\ subluxation\\,\\ dislocation\\,\\ heterotopic\\ bone\\ formation\\,\\ soft\\ tissue\\ swelling\\,\\ sclerosis\\,\\ periostitis\\.\\ \\ most\\ of\\ these\\ are\\ found\\ in\\ the\\ images\\ submitted\\.\\ \\ please\\ see\\ captions\\ for\\ specific\\ findings\\ for\\ each\\ image\\.\ \(0\)\
\-\ charcot\\ joint\ \(0\)\
\-\ the\\ term\\ \\"charcot\\ joint\\"\\ is\\ a\\ general\\ term\\ used\\ to\\ describe\\ severe\\ articular\\ abnormalities\\ related\\ to\\ neurologic\\ deficits\\,\\ regardless\\ of\\ the\\ primary\\ cause\\.\\ \\ the\\ following\\ is\\ a\\ list\\ of\\ some\\ of\\ the\\ causes\\.\ \(0\)\
\-\ 1\\)\\ trauma\ \(1\)\
\-\ 2\\)\\ infection\ \(2\)\
\-\ 3\\)\\ neuropathic\\ osteoarthropathies\\:\ \(1\)\
\-\ \\ \\ \\ a\\)\\ central\\ nervous\\ system\\ disorders\\ \\(syphilis\\,\\ syringomyelia\\,\\ meningo\\-myelocele\\,\\ multiple\\ sclerosis\\,\\ charcot\\-marie\\-tooth\\ disease\\)\ \(0\)\
\-\ \\ \\ \\ b\\)\\ congenital\\ vascular\\ anomalies\ \(0\)\
\-\ \\ \\ \\ c\\)\\ other\\ causes\\ of\\ cord\\ compression\\,\\ injury\\,\\ or\\ degeneration\\ \ \(0\)\
\-\ \\ \\ \\ d\\)\\ peripheral\\ neuropathies\\ including\\ diabetes\\ mellitus\\,\\ alcoholism\\,\\ amyloidosis\\,\\ infection\\,\\ pernicious\\ anemia\\,\\ trauma\\,\\ and\\ intra\\-articular\\ or\\ systemic\\ administration\\ of\\ steroids\\.\ \(0\)\
\-\ 55\\ yo\\ female\\ with\\ a\\ known\\ long\\ history\\ of\\ diabetes\\ mellitus\\ who\\ presented\\ with\\ acute\\ on\\ chronic\\ foot\\ swelling\\ and\\ draining\\ ulcer\\.the\\ patient\\ has\\ had\\ a\\ long\\ history\\ of\\ poorly\\ controlled\\ diabetes\\ and\\ peripheral\\ neuropathy\ \(0\)\
\-\ diabetes\\ is\\ the\\ leading\\ cause\\ of\\ neuropathic\\ osteoarthropathy\\.\\ \\ diabetic\\ neuropathic\\ osteoarthropathy\\ typically\\ appears\\ in\\ patients\\ with\\ long\\ standing\\ poorly\\ controlled\\ diabetes\\.\\ \\ in\\ addition\\ to\\ the\\ progressive\\ loss\\ of\\ sensation\\ and\\ repetitive\\ trauma\\,\\ the\\ findings\\ relate\\ in\\ part\\ to\\ a\\ neurally\\ initiated\\ vascular\\ reflex\\ that\\ leads\\ to\\ increased\\ blood\\ flow\\.\\ \\ the\\ fractures\\,\\ subluxations\\,\\ and\\ joint\\ destruction\\ may\\ represent\\ the\\ terminal\\ event\\ occuring\\ when\\ repetitive\\ mechanical\\ trauma\\ is\\ applied\\ to\\ a\\ site\\ containing\\ bones\\ made\\ weak\\ and\\ vulnerable\\ by\\ hypervascularity\\.\\ \\ this\\ particular\\ patient\\ has\\ had\\ long\\ standing\\ poorly\\ controlled\\ diabetes\\,\\ evident\\ by\\ her\\ hba1c\\ levels\\,\\ and\\ known\\ peripheral\\ diabetic\\ neuropathy\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ diabetes\\:\\ 0\\.06101756171099894\ \(0\)\
\-\ neuropathic\\:\\ 0\\.04128227863419363\ \(0\)\
\-\ destruction\\:\\ 0\\.04058075551761451\ \(0\)\
\-\ joint\\:\\ 0\\.039857152716953094\ \(0\)\
\-\ controlled\\:\\ 0\\.03697095410951367\ \(0\)\
\-\ captions\\:\\ 0\\.031818720416491725\ \(0\)\
\-\ charcot\\:\\ 0\\.031818720416491725\ \(0\)\
\-\ poorly\\:\\ 0\\.03008024657325812\ \(0\)\
\-\ osteoarthropathy\\:\\ 0\\.03005081281973539\ \(0\)\
\-\ long\\:\\ 0\\.02832905298877619\ \(0\)\
\-\ repetitive\\:\\ 0\\.02671837445165873\ \(0\)\
\-\ mellitus\\:\\ 0\\.0258727462475065\ \(0\)\
\-\ neuropathy\\:\\ 0\\.025289280588832137\ \(0\)\
\-\ diabetic\\:\\ 0\\.024528588256068223\ \(0\)\
\-\ submitted\\:\\ 0\\.02429960725131219\ \(0\)\
\-\ wound\\:\\ 0\\.02302964775591995\ \(0\)\
\-\ trauma\\:\\ 0\\.022471238286133934\ \(0\)\
\-\ peripheral\\:\\ 0\\.022297596072217193\ \(0\)\
\-\ standing\\:\\ 0\\.021888646860217225\ \(0\)\
\-\ unknow\\:\\ 0\\.021191150057611775\ \(0\)\
\-\ 6\\.0\\-8\\.0\\:\\ 0\\.021191150057611775\ \(0\)\
\-\ 6months\\:\\ 0\\.021191150057611775\ \(0\)\
\-\ 13\\.0\\-23\\.9\\:\\ 0\\.021191150057611775\ \(0\)\
\-\ dicontinued\\:\\ 0\\.021191150057611775\ \(0\)\
\-\ osteoarthropathies\\:\\ 0\\.021191150057611775\ \(0\)\
\-\ meningo\\-myelocele\\:\\ 0\\.021191150057611775\ \(0\)\
\-\ ulcer\\.the\\:\\ 0\\.021191150057611775\ \(0\)\
\-\ neurally\\:\\ 0\\.021191150057611775\ \(0\)\
\-\ cultures\\:\\ 0\\.021137874116201445\ \(0\)\
\-\ systemic\\:\\ 0\\.01965447406372191\ \(0\)\
\-\ charcot\\-marie\\-tooth\\:\\ 0\\.019524930873573446\ \(0\)\
\-\ \\,\\:\\ 0\\.019522360494035145\ \(0\)\
\-\ evident\\:\\ 0\\.018799248295808025\ \(0\)\
\-\ term\\:\\ 0\\.018799248295808025\ \(0\)\
\-\ pernicious\\:\\ 0\\.01855025513292882\ \(0\)\
\-\ relate\\:\\ 0\\.01855025513292882\ \(0\)\
\-\ hba1c\\:\\ 0\\.01855025513292882\ \(0\)\
\-\ please\\:\\ 0\\.018229028380385683\ \(0\)\
\-\ infection\\:\\ 0\\.017913581063025052\ \(0\)\
\-\ neuropathies\\:\\ 0\\.017858711689535116\ \(0\)\
\-\ findings\\:\\ 0\\.017488816690288074\ \(0\)\
\-\ vulnerable\\:\\ 0\\.01732230892195288\ \(0\)\
\-\ specific\\:\\ 0\\.016982282188598607\ \(0\)\
\-\ a1c\\:\\ 0\\.01688403594889049\ \(0\)\
\-\ amputations\\:\\ 0\\.01688403594889049\ \(0\)\
\-\ disorganization\\:\\ 0\\.01688403594889049\ \(0\)\
\-\ subluxations\\:\\ 0\\.016513481430074965\ \(0\)\
\-\ hypervascularity\\:\\ 0\\.016192492505496786\ \(0\)\
\-\ causes\\:\\ 0\\.01599317643177794\ \(0\)\
\-\ begun\\:\\ 0\\.015025406409867695\ \(0\)\
\-\ occuring\\:\\ 0\\.015025406409867695\ \(0\)\
\-\ sclerosis\\:\\ 0\\.01475632323762666\ \(0\)\
\-\ alcoholism\\:\\ 0\\.014681413997269924\ \(0\)\
\-\ periostitis\\:\\ 0\\.014526273321458455\ \(0\)\
\-\ syringomyelia\\:\\ 0\\.014526273321458455\ \(0\)\
\-\ typically\\:\\ 0\\.014502046968778713\ \(0\)\
\-\ regardless\\:\\ 0\\.01438054105747664\ \(0\)\
\-\ vancomycin\\:\\ 0\\.014113171742307832\ \(0\)\
\-\ cause\\:\\ 0\\.013900301089192145\ \(0\)\
\-\ applied\\:\\ 0\\.013872586505392007\ \(0\)\
\-\ syphilis\\:\\ 0\\.013760759544731209\ \(0\)\
\-\ \\)\\:\\ 0\\.013721878694486636\ \(0\)\
\-\ swelling\\:\\ 0\\.013686590692216984\ \(0\)\
\-\ nervous\\:\\ 0\\.013653904346243627\ \(0\)\
\-\ weak\\:\\ 0\\.013551597580813828\ \(0\)\
\-\ vascular\\:\\ 0\\.013470208018863927\ \(0\)\
\-\ describe\\:\\ 0\\.013268465283562908\ \(0\)\
\-\ past\\:\\ 0\\.013053843615127087\ \(0\)\
\-\ known\\:\\ 0\\.01300024559838375\ \(0\)\
\-\ list\\:\\ 0\\.012860054137420125\ \(0\)\
\-\ amyloidosis\\:\\ 0\\.012860054137420125\ \(0\)\
\-\ intra\\-articular\\:\\ 0\\.012860054137420125\ \(0\)\
\-\ initiated\\:\\ 0\\.012644640294416068\ \(0\)\
\-\ severe\\:\\ 0\\.012640912500317328\ \(0\)\
\-\ hemoglobin\\:\\ 0\\.012511058921447774\ \(0\)\
\-\ negative\\:\\ 0\\.012269808468148435\ \(0\)\
\-\ see\\:\\ 0\\.012260659669369175\ \(0\)\
\-\ heterotopic\\:\\ 0\\.012149803625656095\ \(0\)\
\-\ ulcers\\:\\ 0\\.012094540360692877\ \(0\)\
\-\ terminal\\:\\ 0\\.011787248602255654\ \(0\)\
\-\ chronic\\:\\ 0\\.011572065542822117\ \(0\)\
\-\ leads\\:\\ 0\\.011472276817624876\ \(0\)\
\-\ subluxation\\:\\ 0\\.011430469743798268\ \(0\)\
\-\ event\\:\\ 0\\.011348975629193264\ \(0\)\
\-\ mechanical\\:\\ 0\\.011348975629193264\ \(0\)\
\-\ reflex\\:\\ 0\\.011193834953381793\ \(0\)\
\-\ one\\:\\ 0\\.01113332395822425\ \(0\)\
\-\ articular\\:\\ 0\\.01101300942156067\ \(0\)\
\-\ particular\\:\\ 0\\.01101300942156067\ \(0\)\
\-\ draining\\:\\ 0\\.010910702656130873\ \(0\)\
\-\ anomalies\\:\\ 0\\.010749310101232727\ \(0\)\
\-\ patients\\:\\ 0\\.01063257018925974\ \(0\)\
\-\ each\\:\\ 0\\.010627570358879951\ \(0\)\
\-\ possibly\\:\\ 0\\.010511699921817745\ \(0\)\
\-\ over\\:\\ 0\\.010459820144903667\ \(0\)\
\-\ degeneration\\:\\ 0\\.010428321176654548\ \(0\)\
\-\ containing\\:\\ 0\\.010428321176654548\ \(0\)\
\-\ d\\:\\ 0\\.010244330606648937\ \(0\)\
\-\ anemia\\:\\ 0\\.01021915921273717\ \(0\)\
\-\ prevent\\:\\ 0\\.010194248666978644\ \(0\)\
\-\ interval\\:\\ 0\\.010073426948755354\ \(0\)\
\-\ 55\\:\\ 0\\.009958388436309116\ \(0\)\
\-\ part\\:\\ 0\\.009958388436309116\ \(0\)\
\-\ disorders\\:\\ 0\\.009827237031860956\ \(0\)\
\-\ leading\\:\\ 0\\.009827237031860956\ \(0\)\
\-\ c\\:\\ 0\\.009764250559759938\ \(0\)\
\-\ b\\:\\ 0\\.009682756445154934\ \(0\)\
\-\ dislocation\\:\\ 0\\.0096628073999273\ \(0\)\
\-\ steroids\\:\\ 0\\.0096628073999273\ \(0\)\
\-\ osteomyelitis\\:\\ 0\\.009546469561317085\ \(0\)\
\-\ is\\:\\ 0\\.009461623674742979\ \(0\)\
\-\ sensation\\:\\ 0\\.00943550311477102\ \(0\)\
\-\ deficits\\:\\ 0\\.009399624147904012\ \(0\)\
\-\ represent\\:\\ 0\\.009021450458989258\ \(0\)\
\-\ had\\:\\ 0\\.008864662592503406\ \(0\)\
\-\ for\\:\\ 0\\.008763319094263403\ \(0\)\
\-\ addition\\:\\ 0\\.008708080704510308\ \(0\)\
\-\ site\\:\\ 0\\.008681518598292555\ \(0\)\
\-\ bones\\:\\ 0\\.008668346805589129\ \(0\)\
\-\ general\\:\\ 0\\.008655246794128636\ \(0\)\
\-\ involved\\:\\ 0\\.008616369728634403\ \(0\)\
\-\ neurologic\\:\\ 0\\.008578111422610607\ \(0\)\
\-\ administration\\:\\ 0\\.008528029482940314\ \(0\)\
\-\ foot\\:\\ 0\\.008491141094299303\ \(0\)\
\-\ formation\\:\\ 0\\.008478969695365296\ \(0\)\
\-\ related\\:\\ 0\\.008478969695365296\ \(0\)\
\-\ levels\\:\\ 0\\.008478969695365296\ \(0\)\
\-\ are\\:\\ 0\\.008400532734588474\ \(0\)\
\-\ upon\\:\\ 0\\.008395452992375216\ \(0\)\
\-\ typical\\:\\ 0\\.00823665070709134\ \(0\)\
\-\ to\\:\\ 0\\.008212848239288197\ \(0\)\
\-\ made\\:\\ 0\\.008182385509883313\ \(0\)\
\-\ \\:\\:\\ 0\\.008151020307624988\ \(0\)\
\-\ progressive\\:\\ 0\\.0081188440265464\ \(0\)\
\-\ worsening\\:\\ 0\\.00808769223654038\ \(0\)\
\-\ system\\:\\ 0\\.00808769223654038\ \(0\)\
\-\ unknown\\:\\ 0\\.008016537261116603\ \(0\)\
\-\ images\\:\\ 0\\.007881076403602664\ \(0\)\
\-\ used\\:\\ 0\\.007880250377278755\ \(0\)\
\-\ cord\\:\\ 0\\.007805706538955292\ \(0\)\
\-\ radiographic\\:\\ 0\\.007796549018722918\ \(0\)\
\-\ fractures\\:\\ 0\\.007778337975914125\ \(0\)\
\-\ has\\:\\ 0\\.0077149037042994134\ \(0\)\
\-\ compression\\:\\ 0\\.0076892964574517475\ \(0\)\
\-\ appears\\:\\ 0\\.007645982742301079\ \(0\)\
\-\ abnormalities\\:\\ 0\\.007545107263697636\ \(0\)\
\-\ congenital\\:\\ 0\\.007512401369332783\ \(0\)\
\-\ iv\\:\\ 0\\.007496213791973783\ \(0\)\
\-\ wbc\\:\\ 0\\.007488160698499548\ \(0\)\
\-\ later\\:\\ 0\\.007416871733156067\ \(0\)\
\-\ including\\:\\ 0\\.007416871733156067\ \(0\)\
\-\ labs\\:\\ 0\\.007144168285901775\ \(0\)\
\-\ presentation\\:\\ 0\\.007075482294449717\ \(0\)\
\-\ on\\:\\ 0\\.006960490503513732\ \(0\)\
\-\ by\\:\\ 0\\.00684072549636959\ \(0\)\
\-\ flow\\:\\ 0\\.006788591050140664\ \(0\)\
\-\ central\\:\\ 0\\.006758729223221056\ \(0\)\
\-\ a\\:\\ 0\\.00667355435752454\ \(0\)\
\-\ injury\\:\\ 0\\.006548578225694231\ \(0\)\
\-\ further\\:\\ 0\\.006532317648558313\ \(0\)\
\-\ follow\\:\\ 0\\.006526921807563544\ \(0\)\
\-\ found\\:\\ 0\\.006473619265509886\ \(0\)\
\-\ image\\:\\ 0\\.00641632011129231\ \(0\)\
\-\ some\\:\\ 0\\.006237808302564325\ \(0\)\
\-\ yo\\:\\ 0\\.0061811334694777936\ \(0\)\
\-\ patient\\:\\ 0\\.006177345655647029\ \(0\)\
\-\ her\\:\\ 0\\.00617647033289648\ \(0\)\
\-\ month\\:\\ 0\\.006162534953847619\ \(0\)\
\-\ 6\\:\\ 0\\.0061349042340742175\ \(0\)\
\-\ primary\\:\\ 0\\.006085058324268501\ \(0\)\
\-\ loss\\:\\ 0\\.005962654260741442\ \(0\)\
\-\ two\\:\\ 0\\.005883007782730783\ \(0\)\
\-\ when\\:\\ 0\\.005883007782730783\ \(0\)\
\-\ following\\:\\ 0\\.005829994607935453\ \(0\)\
\-\ all\\:\\ 0\\.005809912234209834\ \(0\)\
\-\ include\\:\\ 0\\.005762388192380497\ \(0\)\
\-\ however\\:\\ 0\\.00571963474903142\ \(0\)\
\-\ history\\:\\ 0\\.005674108354360978\ \(0\)\
\-\ the\\:\\ 0\\.005649610192215477\ \(0\)\
\-\ months\\:\\ 0\\.005610435804543431\ \(0\)\
\-\ blood\\:\\ 0\\.005606757385839663\ \(0\)\
\-\ presented\\:\\ 0\\.0055994173918807915\ \(0\)\
\-\ significant\\:\\ 0\\.005523671036188037\ \(0\)\
\-\ up\\:\\ 0\\.005523671036188037\ \(0\)\
\-\ who\\:\\ 0\\.005355693291206015\ \(0\)\
\-\ these\\:\\ 0\\.005345780509514039\ \(0\)\
\-\ prior\\:\\ 0\\.005274309548563374\ \(0\)\
\-\ bone\\:\\ 0\\.005104410291970842\ \(0\)\
\-\ acute\\:\\ 0\\.005071825310352152\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.005048401532768791\ \(0\)\
\-\ increased\\:\\ 0\\.005025203802403019\ \(0\)\
\-\ soft\\:\\ 0\\.005002227798061419\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.0049513209182265455\ \(0\)\
\-\ 1\\:\\ 0\\.004887803769133911\ \(0\)\
\-\ tissue\\:\\ 0\\.004868800933780273\ \(0\)\
\-\ or\\:\\ 0\\.004815013216171671\ \(0\)\
\-\ 3\\:\\ 0\\.0048100373238137975\ \(0\)\
\-\ was\\:\\ 0\\.004751334241411956\ \(0\)\
\-\ most\\:\\ 0\\.004742392167615568\ \(0\)\
\-\ other\\:\\ 0\\.004734708049765501\ \(0\)\
\-\ were\\:\\ 0\\.004664149847812311\ \(0\)\
\-\ this\\:\\ 0\\.004620851987087178\ \(0\)\
\-\ exam\\:\\ 0\\.0045125815864171595\ \(0\)\
\-\ may\\:\\ 0\\.0045055970406204906\ \(0\)\
\-\ 2\\:\\ 0\\.00442332811661189\ \(0\)\
\-\ but\\:\\ 0\\.004381017550561389\ \(0\)\
\-\ multiple\\:\\ 0\\.0043264567391328584\ \(0\)\
\-\ after\\:\\ 0\\.004250002890887506\ \(0\)\
\-\ female\\:\\ 0\\.0042229814217496\ \(0\)\
\-\ in\\:\\ 0\\.004051896443656298\ \(0\)\
\-\ that\\:\\ 0\\.0035480305974971717\ \(0\)\
\-\ and\\:\\ 0\\.003461711648696509\ \(0\)\
\-\ disease\\:\\ 0\\.0033575421663839043\ \(0\)\
\-\ of\\:\\ 0\\.0030806293480237323\ \(0\)\
\-\ left\\:\\ 0\\.0022983299742137375\ \(0\)\
\-\ right\\:\\ 0\\.0021673839161308094\ \(0\)\
\-\ \\(\\:\\ 0\\.0017364464573169725\ \(0\)\
\-\ \\.\\:\\ 0\\.001706708466218571\ \(0\)\
\-\ with\\:\\ 0\\.0011250401547104783\ \(0\)\
